Si­lence re­ports pos­i­tive PhII cho­les­terol drug da­ta, re­veals end to Mallinck­rodt al­liance

Si­lence Ther­a­peu­tics has re­port­ed its siR­NA drug can­di­date showed pos­i­tive re­sults in a mid-stage test of pa­tients with high low-den­si­ty lipopro­tein at risk of car­dio­vas­cu­lar …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER